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Abstract: G-quadruplexes (G4s) are four-stranded nucleic acid structures whose underlying G-
rich sequences are present across the chromosome and transcriptome. These highly structured 
elements are known to regulate many key biological functions such as replication, transcription, 
translation, and genomic stability, thereby providing an additional layer of gene regulation. G4s 
are structurally dynamic and diverse, and can fold into numerous topologies. They are potential 
targets for small molecules which can modulate their functions. To this end, myriad classes of 
small molecules have been developed and studied for their ability to bind to and stabilize these 
unique structures. Though many of them can selectively target G4s over duplex DNA, only a few 
of them can distinguish one G4 topology from others. Design and development of G4-specific 
ligands are challenging owing to the subtle structural variations among G4 structures. However, 
screening assays and computational methods have identified a few classes of ligands that 
preferentially or specifically target the G4 topology of interest over others. This review focuses 
on the small molecules and fluorescent probes that specifically target human promoter G4s 
associated with oncogenes. Targeting promoter G4s could circumvent the issues such as 
undruggability (lack of druggable sites) and development of drug resistance associated with 
protein targets. The ligands discussed here highlight that development of G4-specific ligands is 
an achievable goal in spite of the limited structural data available to date. The future goal of the 
field is to pursue the development of G4-specific ligands endowed with drug-like properties for 
G4-based therapeutics and diagnostics.   
Introduction 
Certain G-rich nucleic acid sequences are capable of folding into four-stranded structures called 
G-quadruplexes (G4s), which are formed by stacking of two or more G-quartets in the presence 
of metal ions such as K+ and Na+ (Figure 1).1 G4s adopt various structural topologies such as 
parallel, antiparallel, mixed-type (hybrid) with right-handed helicity, depending on the nature 
and length of the loops, flanking sequences, nature of metal ions, and environmental conditions. 
The structural space and complexity are more likely to broaden with the recent finding of a left-
handed G4 motif.2 A high-throughput sequencing method, G4-seq, identified 716,310 potential 
G4 forming sequences in the human genome, which vastly exceeds the number of sequences, 
~370,000, predicted by the computational algorithms that had not considered the long-loop (> 7 
nt) and bulges in the strands.3 However, only ~10,000 endogenous G4 structures have been 
identified within the context of human chromatin by the G4-ChIP-seq.4 G4 structures have been 
visualized at the telomere, across the chromosome, and in the transcriptome by using G4-specific 
antibodies and fluorescent ligands.5-9  
G4s are known to play critical roles in fundamental cellular functions such as telomere 
maintenance, replication, genome stability, transcription, and translation.10 They can impede 
the replication and are the source of genome instability when the G4 helicase activities are 
impaired.11, 12 Telomeric G4 interferes with the function of telomerase, whereas promoter G4s 
regulate transcription.13 The RNA G4s located in 5’-UTRs modulate translation in both cap-
dependent and cap-independent mechanisms, while those located in the certain 3’-UTRs 
involved in the alternative polyadenylation and regulation of micro RNAs.14-16 Also, several 
cellular proteins including nucleolin, PARP1 and FMR2 bind to G4s; various helicases such as 
Pif1, RecQ, FANCJ, WRN, BLM, and RHAU unfold the G4s, underscoring a myriad number 
of roles played by these structures.17, 18   
 
 
Figure 1. Schematic representation of G-quartet and representative topologies of telomeric and 
promoter G4s. G-quartet, also known as G-tetrad, formed by the self-association of four guanine bases 
through Hoogsteen hydrogen bonding; stacks of two or more quartets result in folding of G4s, which 
are stabilized by monovalent metal ions (M+). The nucleotides that constitute the loops are shown in 
the green sphere. Loops are categorised into three different types, namely diagonal, lateral, and chain 
reversal (propeller). Telomeric G4s: parallel (PDB: 1KF1),19 basket-type antiparallel (PDB: 143D),20 
hybrid-1 (PDB: 2GKU),21 hybrid-2 (PDB: 2JPZ),22 2-quartet basket type antiparallel (PDB: 2KF8)23 
and chair-type antiparallel (PDB: 5YEY).24 Promoter G4s: c-MYC (PDB: 1XAV)25 and c-KIT2 (PDB: 
2KQH).26 The parallel G4 strands are connected via three propeller loops, whereas antiparallel ones are 
through two lateral and one diagonal loops, and hybrid G4s have two lateral and one propeller loops.  
 
  G4s are highly dynamic and readily fold under the physiological condition in vitro.1  
Formation of G4s in the chromatin and transiently-folded RNA G4s in the transcriptome have 
been observed, which can be targeted and stabilized by an exogenous small molecule. 4, 27 G4s 
are therapeutic targets for small molecules that induce double-strand breaks (DSB), DNA 
damage response, and synthetic lethality in cancer cells.28-31 G4s are also potential targets for 
neurodegenerative diseases.32 Interestingly, two G4 binding small molecules, quarfloxin 
(CX-3543) and CX-5461, reached the clinal trial for the treatment of cancer.30, 33 CX-5461 is 
directed towards breast cancer tumor suppressor genes (BRCA1/2) deficient tumors, while 
CX-3543 was terminated in Phase II due to its bioavailability issue.30, 33 Moreover, findings of 
G4 structures in virus, bacteria, and parasites open up avenues for targeting them with small 
molecules, highlighting their importance in human health.34, 35  
Structure and function of G4s 
Telomeric G4 DNA is highly polymorphic and is known to adopt various G4 topologies (Figure 
1). The 22nt human telomeric DNA, AG3(T2AG3)3, adopts antiparallel topology under Na
+ ions, 
but the same sequence crystalized into the parallel form in the presence of K+ ions.19, 20 
Depending on the particular flanking nucleotides, multiple G4 topologies such as hybrid-1, 
hybrid-2, and 2-tetrad antiparallel G4s have been reported for the telomeric DNA (Figure 1).1 In 
the presence of crowding agents such as polyethylene glycol (PEG), telomeric G4 adopts parallel 
form owing to conformational selection and dehydrating effect of PEG.36, 37 However, when 
Xenopus laevis egg extract was used as a crowding agent, the hybrid-1, hybrid-2, and 2-quartet 
antiparallel G4s (Figure 1) were found to be the only biologically relevant conformations,38, 39 
which were also observed in living human cells.40 Formation of higher-order G4s (tandem G4s)41 
further complicates the relevant conformation needed for the ligand design and screening.  
The promoter regions of proto-oncogenes such as c-MYC, c-KIT, BCL-2, VEGF, SRC, 
hTERT, RET, PDGFR-β,  PDGF-A, KRAS, HRAS, HIF-1α, and c-MYB contain G-rich sequences, 
which have a propensity to form stable G4 structures.33 The negative superhelicity induced by 
transcription and molecular crowding conditions favor the formation of the G4 structure in G-
rich strands and the i-motif in the C-rich strands from the corresponding duplex DNA.42, 43 The 
concurrent or mutually exclusive formation of G4 and i-motif from corresponding duplex 
sequence depends on the distance between the two secondary structures.44, 45 The dynamic G4 
structure can be stabilized by a small molecule ligand, thus the resulting stable G4 poses a 
challenge to transcription machinery, which results in repression of the associated gene 
expression (Figure 2).46 One of the most studied promoter G4s is c-MYC, whose overexpression 
leads to ~ 80% of all solid tumors, including medulloblastomas, breast, ovarian, and 
gastrointestinal cancers.33, 47 The nuclease hypersensitive element (NHE) III1 that is critical for 
regulating c-MYC expression comprises a 27-nt G4 forming sequence from  ̶ 115 to  ̶ 142 bp 
upstream of the transcription start site.25 MYC protein constitutes an “undruggable” target, 
because it is an intrinsically disordered protein that lacks a defined enzymatic site or binding 
pocket, and thus it is not amenable to small-molecule inhibition.48 In this context, c-MYC G4 
provides an attractive target for small molecules to regulate its expression.47 An exon-specific 
assay involving CA46 cells has been used to validate whether ligand-induced down-regulation of 
the c-MYC mRNA expression is directly mediated via targeting corresponding G4 or not .49, 50  
c-KIT is another proto-oncogene, which encodes for a tyrosine kinase receptor. Two G4 
forming sequences namely KIT1 (from  ̶ 87 to   ̶109 bp) and KIT2 (from  ̶ 140 to  ̶ 160 bp) are 
located in the upstream of transcriptional start site of KIT gene.51, 52 Mutation and overexpression 
of c-KIT protein is associated with gastrointestinal stromal tumors (GISTs) and the mesenchymal 
tumors of the stomach and proximal small intestine.53 Drug resistance issue associated with the 
small molecules targeting c-KIT protein warrants c-KIT G4s to be considered an alternative way 
to regulate its expression by small molecules.54  Structural analysis of promoter G4s indicates 
that most of G4s such as c-MYC, c-KIT, VEGF, RET, and HIF-1α comprise single-nucleotide 
loops (first and third) and a loop having variable-length in the middle; the short loop-size favors 
the parallel topology (Figure 1).55, 56 Other promoter G4s such as BCL-2 and hTERT fold into 
hybrid forms, besides parallel forms. 55, 57, 58  
 
 
Figure 2. Proposed transcriptional regulation of promoter G4s. Transcriptionally induced 
negative super helicity, G4-associated proteins, and molecular crowding are likely to favor the 
formation of secondary structures. 
 
G4 formation at the 5’-UTRs of many genes such as NRAS, ZIC1, MT3-MM3, BCL-2, 
and ERS1 is known to repress the translation process, whereas G4 formation at 5’UTRs of FGF-
2 and VEGF promotes the translation.14 Furthermore, the G-rich telomeric repeat-containing 
RNA (TERRA) is known to fold into a parallel G4 structure.1 Formation of G4s has also been 
reported near the ribosomal RNA (rRNA) tentacles.59 Unlike structural diversity of DNA G4s, 
RNA G4s are mostly known to fold into the parallel topology, with the exception of recent 
finding suggesting the formation of antiparallel G4 RNA.60 Due to the steric constraint imposed 
by 2’-OH group, the ribose sugars favor mostly the anti-conformation of the glycosidic bond, 
which in turn leads to the parallel topology. There also exist conformational dynamics between a 
hairpin and G4 for some G-rich RNAs.61  Despite a recent finding suggesting that RNA G4s are 
globally unfolded in vivo,62 small molecule based high-throughput sequencing (G4RP-seq) 
identifies in vivo existence of transiently folded RNA G4s in the transcriptome.27 
Specific targeting of G4s 
G4-specific ligands and fluorescent probes are warranted at least for the following reasons: 1) 
indiscriminate and stochastic binding to all G4 may lead to breaks in replication fork and can 
induce genome instability,63-65 2) in order to understand the formation and function of a G4s of 
interest in the genome, 3) G4-specific therapeutic intervention to alleviate off-target toxicity, 4) 
locus-specific visualization and identification of G4s, and 5) to find out whether the G4 of 
interest is folded or not in both in vitro and in vivo. The focus of the review is to highlight the 
limited success achieved in the design and development of ligands that stabilize promoter G4s 
specifically over related G4s and duplex DNAs. Besides, the probes that sense the promoter G4s 
selectively through their fluorescence light-up are discussed.  
A number of ligands targeting G4 structures with superior selectivity over the duplex 
DNA have been reported.31, 54, 66-69 However, specificity towards a G4 of interest over other 
structurally similar G4s is a challenging task given their subtle structural variations in loops 
(length, composition, and type), groove widths (narrow, medium and wide) and flanking 
nucleotides.70 This is further complicated by the ligand-induced fit that alters the loop 
conformation, groove dimension and flanking nucleotide arrangement, and by the 
conformational selection that transduces the polymorphic G4s into a ligand-favored topology.36, 
68, 71, 72 Though a limited number of small molecules have shown specific binding preference for 
a particular G4 over others,73-81 the fundamental question remains whether the challenge of 
designing such molecules is worth to pursue given that complex diseases such as cancer that 
involves intricately multiple pathways and genes.82  Even if the ligands are specific toward a 
particular type of G4s, screening against the overwhelmingly available structurally related G4s is 
a daunting task. On the other hand, whether all the potential G4 forming sequences can fold into 
G4s in cells is unclear, as it depends on how stable the folded G4s are under in vivo conditions 
and on the cell types/cycles.5, 83, 84 Indeed, the folded G4 structures in the chromatin is fewer than 
the predicted number of G4 forming sequences,4 implying folding of G4s might be constrained 
and suppressed in chromatin. Besides stabilizing and binding to several G4s, the well-known G4 
binder pyridostatin most strongly affects the SRC protooncogene,64 underscoring the fact that 
accessibility to G4s for small molecules may also be limited. 
Specific targeting of promoter G4s by small molecules 
Pyridine, 1,8-naphthiridine, and 1,10-phenanthroline based bisbenzimidazole carboxamide 
derivatives with strategically positioned flexible dimethylamino alkyl side chains were screened 
for their ability to stabilize telomeric, and promoter G4s.85 Various biophysical and biochemical 
studies were utilized to validate the specificity of these ligands for the promoter c-MYC and c-
KIT G4 DNAs. The lead ligand Phen-Et (Figure 3) imparted higher stabilization to promoter c-
MYC and c-KIT G4 DNAs (maximum ∆T1/2 = ~20 °C) than to any of the telomeric G4 topologies 
(antiparallel, parallel, hybrid and higher-order) and duplex DNAs. NMR studies indicated that 
Phen-Et binds to G4 through end-stacking with 1:1 stoichiometry. UV-Vis titration experiments 
showed that ligand bind specifically (Kd =15.6 µM) to c-MYC G4 DNA over telomeric and 
duplex DNA. Molecular modeling and dynamics (MD) studies revealed that the ligand by 
reorienting 5’ flanking nucleotides of c-MYC G4 maximizes the accessible surface area for 
favorable stacking interactions with the G-quartet of c-MYC G4. Moreover, the MD studies 
highlighted the importance of flexible N-alkyl side chains attached to the benzimidazole-scaffold 
in recognizing the propeller loops of the promoter G4 DNAs in achieving the specificity.85 
 




Indenopyrimidine derivative comprising a flexible side chain protruding with pyrrolidine 
has been reported to specifically stabilize promoter c-MYC and c-KIT1 G4s as compared to their 
telomeric counterpart (Inpy1 in Figure 3).86 Inpy1 imparts high stability (maximum ∆T1/2 =  
~9.6 °C) to c-MYC and c-KIT1 G4s over the telomeric G4 DNAs (∆T1/2 = ~1.5 °C). Stern-
Volmer binding constant analysis using fluorescence titrations revealed that its binding affinity 
for c-MYC G4 is one order magnitude higher than that obtained for telomeric G4.86 MD studies 
showed that InPy1 stacks on the both quartets and makes unique contacts with propeller loops 
and flanking nucleotides. Besides,  benzene ring attached to the indenopyrimidine core is also 
crucial for the observed target specificity.86  
Benzothiazole hydrazones of furylbenzamides containing different side chains have been 
studied for their ability to interact with various G4s. The lead ligand (BHFB-2 in Figure 3)  
exhibited preferential stabilization of c-MYC and c-KIT1 promoter G4 DNAs over the telomeric 
and antiparallel HRAS-1 G4s.87 Aromatic moieties of BHFB-2 stacks well on the 5’-end of the 
G-quartets of c-MYC and c-KIT1, while the positively charged side chain involves in electrostatic 
interaction with a propeller loop .87 
Indolylmethyleneindanone aromatic core with varying length of alkyl-pyrrolidine side 
chains was reported for their specific stabilization of parallel topology of promoter c-MYC and c-
KIT G4 DNAs.88 The lead ligand InEt2 (Figure 3) is water soluble and has desirable drug-like 
properties. It imparted high stability to c-MYC and c-KIT1 and c-KIT2 G4s (ΔT1/2 up to 22 °C) 
and did not stabilize the telomeric G4 DNA. ITC and ESI-MS experiments indicated that InEt2 
binds (Kd = ~1-10 µM) to promoter G4 with 2: 1 stoichiometry (InEt2: G4).
88Molecular 
modeling and dynamics studies demonstrated both the 5'- and 3'-ends of G-quartets are the 
binding sites for InEt2.88   
Several derivatives naphthalenediimides (NDIs) have been explored as G4 stabilizing 
agents.54, 72 Interestingly, the recently reported amino acid functionalized NDIs exhibited specific 
stabilization of promoter G4 as compared to telomeric G4.89 Notably, NDI 1 (Figure 3) imparted 
stability to both c-KIT2 and c-MYC, while NDI 3 was even able to distinguish c-KIT2 (ΔT1/2 
=14.6 °C) from c-MYC (ΔT1/2 = 0.1 °C).
89 This study highlights the profound effect of the amino 
acid side chains in differentiating two closely related promoter G4s. On the other hand, the role 
of the unusual BOC (t-butyloxycarbonyl) group in the side chains remains to be elucidated.   
Attachment of carbazole moiety into a triaryl-substituted imidazole resulted in a four-leaf 
clover-like ligand IZCZ-3 (Figure 3).90 Fluorescence studies indicate that ligand binds to c-
MYC G4 with 1:1 stoichiometry and a Kd of ~0.1 µM. The thermal melting analysis showed that 
IZCZ-3 imparted high thermal stability to c-MYC G4 (ΔT1/2 = 20 °C) and had little effect on 
other G4s from telomeric, HRAS, c-KIT1, BCL-2, and KRAS, highlighting specific stabilization 
to c-MYC G4.90 Cellular studies indicated that the ligand effectively down-regulates c-MYC 
transcription and inhibits cancer cell growth. It also inhibits cervical squamous cancer growth in 
mouse xenograft models.90  
Small molecule microarray screening of 20,000 molecules led to the identification one 
drug-like small molecule capable of binding to c-MYC G4 selectively.91 Further optimization 
resulted in DC-34 (Figure 3) that binds to c-MYC G4 with a Kd of 3.5 µM.
92 The structure-
activity relationship of DC-34 indicated that electron-withdrawing CF3 group at para position on 
the benzene ring and azepane ring are crucial in maintaining its affinity and ability to suppress 
MYC expression. The molecule specifically stabilizes c-MYC G4 over several other G4s derived 
from KRAS, MYB, HIF1, and telomeric region.92 Gene expression analysis measured by qPCR 
indicated that DC-34 substantially downregulats the MYC RNA level as compared to other G4 
forming genes. Detailed structural analysis of ligand-G4 complex revealed that DC-34 binds at 
both 5’ and 3’ end quartets, forming 2:1 complex using stacking, hydrogen bonding, and cation-π 
interactions (Figure 4).92 The oxygen atom from benzofuran and fluorines from trifluoromethyl 
group involved in hydrogen-bonding with the nucleobases of the receptor (Figure 4C).  Owing 
to its short loops and flexible flanking sequences, c-MYC G4 provides the more accessible 





Figure 4. Structure of c-MYC G4 with ligand DC-34 (structure shown in Figure 3), derived from NMR 
(PDB: 5W77).92 K+ ions are shown in purple-sphere; the strand backbone and nucleosides are represented 
in cartoon and stick model. A) The 2:1 (Ligand: G4) complex showing π-π interaction between the ligand 
and top- as well as bottom-quartet (side view). While benzofuran and para-trifluoromethylbenzene 
rings of DC-34 involve in stacking interactions, the azepane ring is directed away from the quartet. B) 
Ligand stacks on the 5’-quartet (axial view). C) Ligand stacks on the 3’-quartet shown in axial view.  The 
3’-quartet includes the flanking nucleotides; the hydrogen bonds between the ligand and nucleobases are 
shown in dotted line. Figures are rendered using PyMOL.  
 
Furopyridazinone-based compounds were screened to explore their ability to stabilize 
various G4s.93 Results showed that the lead ligand 3 (Figure 3) binds   and stabilizes the BCL-2 
G4 (Kd = ~1.6 µM) specifically over other promoter and telomeric G4s, and duplex DNA.
93 
Cellular assays showed that Jurkat cells treated with 3 downregulated BCL-2 mRNA level and  
its protein expression significantly, validating the biophysical assays.93 Given the limited number 
of small molecules, reported to date, have drug-like properties, the furopyridazinone core is 
highly desired for further derivatization toward the development of G4 specific ligands.  
In order to develop G4-ligands with drug-like properties, recently, a bioinspired approach 
was adopted wherein nucleobase-based scaffolds were initially screened against various G4s.94 
Initial screening based on CD melting led to the identification of a lead compound that stabilizes 
promoter G4s over telomeric and hairpin-duplex DNA.94 Subsequent screening of analogs 
rendered compounds including 12 (Figure 3), which is found to be highly specific to BCL-2 and 
c-MYC G4s. Compound 12 binds to c-MYC (Kd = ~ 26 µM) and BCL-2 (Kd = ~ 60 µM) and 
represses their expression levels of the mRNA and protein.94  Binding analysis indicated that 12 
stacks on 5’-quartet of c-MYC, whereas it binds to 3’-quartet in case of BCL-2. Compound 12 
has potential to become a G4-based therapeutic agent due to its desirable drug-like properties 
such as having low-molecular weight, water-solubility and  non-toxicity.94  
Fluorescent probes specifically recognizing promoter G4s 
Various commercially available probes such as thiazole orange (TO),95 thioflavin T (ThT),96and 
N-Methyl mesoporphyrin IX  (NMM),97 have been utilized as G4 sensing probes and in ligand-
screening assays. Besides, various synthetic probes98 have been developed to visualize the G4s in 
vitro as well as in cellular environment.7, 99, 100 G4s offer ideal hydrophobic microenvironment 
for fluorophores to bind, which induce various structural effects in the fluorophores such as 
planarity, rigidity, hydrophobicity, monomer formation (from aggregates) upon photoexcitation, 
thereby resulting in their fluoresce light-up.96, 101 Several smart G4 specific fluorescent probes 
are currently being developed by systematic screening against various G4s. Here the probes 
(Figure 5) that distinguish promoter G4s from other G4s are discussed.  
 
Replacement of one pyridine rings in BMVC (3,6-bis(1-methyl-4-vinylpyridinium) 
carbazole diiodide)102 by a benzindole moiety, and other modifications rendered a fluorescent 
probe 9E PBIC (Figure 5, Table 1) with a longer emission wavelength.103 9E PBIC specifically 
enhanced its fluorescence over 100-fold in the presence of c-MYC G4, compared to 30-fold 
enhancement observed in the presence of other promoter and telomeric G4s. On the other hand, 
only a marginal fluorescence enhancement was observed with other nucleic acids.  9E PBIC 
binds to c-MYC G4 (Kd = ~10 µM) via an end-stacking mode with 1:1 stoichiometry.
103  
Carbazole TO (Figure 5, Table 1) specifically enhanced its fluorescence over 70-fold in 
the presence of BCL-2 G4 as compared to less than 30-fold observed with promoter  (c-MYC, c-
KIT1, and VEGF) and telomeric G4s and other nucleic acids.104 In addition, Carbazole TO is 
able to detect BCL-2 G4 down to 0.6 nM concentration. The quasi-planar conformation of 
Carbazole TO stacks effectively on the G-quartet of the BCL-2 G4, with a Kd of ~2.9 µM.
104 
Detailed structural studies are warranted to elucidate the role of the carboxylic acid side chain in 
the G4 recognition.  
An acetylene-bridged 6,8-purine dimer (APD in Figure 5, Table 1) was reported as a 
selective fluorescent probe for various parallel G4 DNAs (c-MYC, c-KIT1, c-SRC1) and RNAs 
(BCL-2, NRAS, TERRA) over antiparallel promoter and telomeric G4s.105 The APD dye 
selectively stains parallel G4 DNAs and RNAs over duplex and telomeric G4 DNAs in agarose 
gels. The marked fluorescence enhancement in the presence of parallel G4s was ascribed to the 
change in rotational diffusion of acetylene bond upon binding G4s via end-stacking.105 Though 
selectivity between parallel promoter G4s and RNA G4s remains to be addressed, this core 
structure provides an opportunity for further molecular tweaking in order to make it specific to 
parallel promoter G4s. Although parallel G4s exist among telomeric DNA, several promoter 
DNAs, UTR RNAs, and telomeric RNA, the propeller loops present in them are distinct. For 
example, parallel telomeric G4 contains 3-nt long propeller loops, whereas c-MYC has short (two 
1-nt and one 2-nt loops) propeller loops (Figure 1). In case of RNA G4s, they have 2’-hydroxyl 
functional groups. These subtle structural variations and the additional 2’-hydroxyl groups could 
be used to design probes for parallel promoter G4s. 
 
 
















9E-PBIC 530, ~600 c-MYC 103 
Carbazole 
TO 
500, 605 BCL-2 104 
APD 430, 510  c-SRC1, c-KIT1, 
RNA G4s 
105 
15 450, 525  KRAS, c-MYC, 
c-KIT2, BCL-2 
106 
IZFL-2 450, 520 c-MYC 107 
CSTS  680, 710  c-MYC, c-KIT2 101 
SQgI 661, 700  VEGF, CEB25, 
VAV-1, c-MYC, 
108 




2 650, 685-695 CEB25, c-MYC, 
BCL-2,  
110 
ThT-HE 415, 485 c-MYC 111 
9CI 405, 472 c-MYC 112 
Hyp 555, ~610  c-MYC, c-KIT2 113 
1b 470, 595 HRAS 114 
L-1 463, 590  c-MYC 115 
 
Derivatives of 2,4,5-triaryl-substituted imidazole are known to display parallel G4-
specific fluorescence enhancement.106, 116, 117 Target(G4)-guided synthesis involving 
triarylimidazole containing alkyne group as the binding substrate and various azide compounds 
as side chains followed by in situ click chemistry resulted in the formation of compound 15 
(Figure 5, Table 1).106 The compound 15 displayed a marked fluorescence enhancement upon 
binding to KRAS, c-MYC, c-KIT2, and BCL-2 G4s, whereas it weakly fluoresced in the presence 
of HRAS, telomeric G4, and other nucleic acids.106 Compound 15 was also used as a specific 
staining agent for parallel G4s in the gel.106  
A smart fluorescent probe IZFL-2 (Figure 5, Table 1) was designed by harnessing the 
photoinduced electron transfer (PeT) mechanism.107 The PeT based probe was rationally 
constructed by attaching the fluorescein moiety to the triarylimidazole moiety (a G4 ligand) 
through an appropriate linker.107 Fluorescence studies on IZFL-2 and various G4s showed a 
distinct response for c-MYC G4. Among all the tested G4s that include telomeric, c-MYC, c-
KIT1, c-KIT2, BCL-2, KRAS, VEGF, etc., IZFL-2 exhibits a fluorescence enhancement (> 10-
fold) only in the presence of c-MYC G4, indicating its exquisite specificity to a particular G4 
structure. Upon binding to c-MYC G4, IZFL-2 suppresses the intramolecular PeT process, 
thereby restoring its fluorescence.107 This smart probe is one of the very few probes that 
recognize one particular G4 among other structurally similar promoter G4s.  
  Many of squaraine based molecules exhibit specific recognition of promoter G4s as 
compared to their telomeric counterpart.101, 108, 109, 118 A dicyanomethylene-functionalized 
squarine dye with bisbenzothiazole was reported (CSTS in Figure 5, Table 1) as a selective 
probe for parallel G4s.101 The presence of dicyanomethylene group on the central squaraine 
forces CSTS to be a crescent-shaped cisoid conformation due to steric congestion.101 CSTS self-
aggregates and thus exists in the H-aggregate form (non-fluorescent) in an aqueous solution. 
However, it disassembles and converts into the monomeric form in the presence of parallel G4s 
such as c-MYC and c-KIT2, thereby enhancing its fluorescence .101 Fluorescence studies with 
other G4 topologies including telomeric DNA indicated that it specifically recognizes the parallel 
G4s over mixed-type and antiparallel ones.101  
To overcome the low fluorescence light-up observed with CSTS, an amphiphilic 
squaraine derivative with two triethylene glycol chains (SQgI in Figure 5, Table 1) was 
reported.108 SQgI enhanced its fluorescence light-up by 20,000-fold  in the presence of various 
promoter G4s such as VAV-1, BCL-2, VEGF, c-MYC, etc. as compared to the low-level light-up 
observed with telomeric G4 and other nucleic acids. SQgI forms a sandwich-type complex 
(SQgl/G4, 1:2) with promoter G4, while the triethylene glycol side chains interact with the 
propeller loops through hydrogen bonding interactions.108 Further optimization of SQgl led to 
the development of a superior probe (CAS-C1 in Figure 5) with improved water solubility, 
enhanced binding affinity and red-shifted excitation wavelength (720 nm in the NIR region).109  
The CAS-C1 comprises six triethylene glycol chains that improve its water solubility and also 
strengthen the non-covalent interactions with the residues in the grooves.109 Dissociation 
constants of CAS-C1 for various promoter G4s (for example, ~100 nM for c-MYC) were found 
to be two-order magnitude less than those of SQgI (~8.3 µM for c-MYC). The observed 
specificity toward parallel G4s was ascribed to the fact that the G-quartet surface areas of 
parallel G4s are highly accessible for squaraine core to stack as they are devoid of diagonal and 
lateral loops.109 Moreover, CAS-C1-parallel G4 systems exhibit high fluorescence quantum 
yields and large two-photon absorption cross-sections, making  CAS-C1 an ideal probe for in 
vivo applications.   
Thioflavin T (ThT) is a selective fluorescence sensor for various G4 nucleic acids.96, 119, 
120 It also elicits its fluorescence response upon binding to the G4 RNA aptamer (Corn).121 In 
order to distinguish one G4 from others, the methyl group present at N3 position on the 
benzothiazole ring of ThT was modified into a hydroxyethyl group (ThT-HE in Figure 5, 
Table 1).111 Fluorescence studies indicated that ThT-HE strongly fluoresced (up to ~240-fold) 
in the presence of c-MYC (27-mer) G4, whereas it weakly fluoresced  in presence ofother nucleic 
acids such as telomeric and other promoter G4s, ss-DNA and ds-DNA.111 Overall, ThT-HE can 
address the issues such as G4 specificity and fluorescence sensitivity associated with the ThT.  
The core-extended naphthalenediimide comprising three diethylene glycols (2 in Figure 
5, Table 1) as side chains exhibited high fluorescence light-up (up to ~250-fold) in the presence 
of several parallel G4s of the minisatellite (CEB25), c-MYC, BCL-2 etc.110 On the other hand, it 
displayed a moderate fluorescence response in the presence of other non-parallel G4s. 
Compound 2 was able to specifically stain parallel G4s in gels.110 The study also highlights the 
role of diethylene glycol side chains in achieving specific recognition of parallel G4s.    
Structure-based virtual screening and subsequent lead optimization resulted in a specific 
fluorescent probe containing anthracene attached to a triazine derivative (9CI in Figure 5).112 
Fluorescence studies showed  that 9CI recognizes the c-MYC G4 with high specificity over other 
promoter G4s (c-KIT1, c-KIT2, VEGF, KRAS, etc.,),  human telomeric G4 and non-G4 forming 
sequences.112  In addition, 9CI was able to specifically stain c-MYC G4 over other nucleic acids 
in gel-based assay and was able to detect c-MYC G4 as low as 3 nM.  One of the potential 
applications of 9CI includes visualization of aptamer-protein binding interactions.112 
Fluorescence studies on hypericin (Hyp in Figure 5, Table 1), which is one of the main 
components of Saint John’s wort (Hypercium), with various nucleic acids pointed out its 
preference for the c-KIT2 and c-MYC G4s over telomeric G4 and single-stranded and duplex 
DNAs.113 The Hyp exists in aggregated forms in the aqueous environment, owing to 
hydrophobic interactions and hydrogen bonding.113 On the other hand, formation of the 
monomeric forms contributes to its fluorescence light-up behavior in the presence of c-KIT2 and 
c-MYC G4 DNAs.113 Binding mode analyses by NMR, Docking, and G4/hemin peroxidase 
inhibition studies indicated that Hyp stacks onto the top quartet of the parallel G4s.113  
Triphenylamine-quinolinium derivative with 2-(dimethylamino)ethyl amino group as a 
side chain was reported as a selective G4 fluorescent probe.122 Further optimization with the side 
chain length into the 3-(dimethylamino)propyl amino group resulted in probe 1b (Figure 5, 
Table 1) that is highly selective for HRAS G4 (antiparallel form) over other promoter and 
telomeric G4s.114 1b exhibited more than 180-fold emission enhancement in the presence of 
HRAS G4. Further, 1b could be used to detect HRAS G4 with a limit of detection ~1.12 nM. 
Interestingly, 1b was found to be cell-permeable and provided a red signal in nucleoli, 
demonstrating its potential application in live-cell imaging.114 This study highlights the critical 
role of length of the amine side chain in distinguishing HRAS G4 over other G4 structures. 
A fluorescent probe based on benzo[f]quinolinium derivative with styryl moiety was 
reported for selective recognition of c-MYC G4 (L-1, Figure 5, Table 1).115 The probe exhibited 
red emission and a large stock shift in the presence of c-MYC G4. Fluorescence studies with 
other nucleic acid indicated that L-1 enhanced its fluorescence by 550-fold in the presence of c-
MYC G4. In contrast, it exhibited a moderate fluorescence enhancement (up to 310 fold) in the 
presence of other G4s and a low enhancement (up to 110-fold) with other nucleic acids.115 
Molecular docking study showed that the -OH group in the N-(2-hydroxyethyl)piperazine side 
chain involved in the hydrogen bonding with the negatively charged phosphate backbone of the 
c-MYC G4. Further, the side chain was found to be critical in sensing c-MYC G4 as the 
replacement of the hydroxyethyl by phenyl group resulted in the loss of fluorescnce emission.115 
Moreover, L-1 is cell permeable and able to localize inside the nucleus, thus showing its live-cell 
imaging application.   
Summary and Outlook 
Overall, the ligands (Figures 3 and 5) can specifically or preferentially recognize promoter G4s 
over the telomeric and duplex DNAs, which was once considered to be an insurmountable task. 
Given that the limited structural details available for the G4-ligand complexes on G4 
discriminating ligands, and most of the G4-specific ligands reported to date are results of 
serendipitous findings, it is difficult to come up with the general structural features for the 
rational design of promoter-specific ligands. The reason on why some ligands recognize a 
particular G4 structure remains an outstanding question. Structural studies are warranted to 
understand how the functional groups in the ligands are involved in the recognition of unique 
loops of a particular G4 structure. The limited structural and molecular modeling studies indicate 
that G4 specific ligands access the available surface area on the G-quartets and maximize the π-π 
stacking by reorienting the flexible flanking sequences at the 5’- or 3’-ends. This is likely to be 
facilitated by the other additive and cooperative functional contacts by the side chains of ligands 
with the unique accessible loops. 
  The limited success achieved in the last few years provides some hints for the design of 
specific ligands. For example, the central core of the well-known G4 stabilizing agents should be 
considered as leads, to which varying-lengths of flexible alkyl side chains containing functional 
groups (-N and -O based) are to be strategically attached so as to target unique loops, as reported 
for Phen-Et, NDI 1, NDI 3, 1b and ThT-HE (Figures 3 and 5). Additionally, the number, 
length, and position of the side chains are likely to play a crucial role in making the ligands to be 
topology specific.   
High-throughput methods help screen the vast chemical space of drug-like small 
molecules. In this direction, the small molecule microarray screening method is promising as it 
allows one to screen thousands of molecules in a single set of experiments.91 Prior to the 
intended screening with the G4 of interest, depleting number of small molecules that bind to the 
other related G4s and other nucleic acids will aid in identifying G4 specific ligands. Further, the 
target-guided synthesis approach123 has also the potential to find the small molecules capable of 
binding to a specific G4. For example, one can exclude the non-specific ligands from the library 
by incorporating appropriate control experiments with unintended G4 targets before performing 
screening with the intended target.   
The success in the development of smart probe (IZFL-2 in Figure 5) implies that G4 
specific ligands could judiciously be assembled with appropriate fluorophores and linkers by 
utilizing PeT process. Moreover, the presence of triaryl-substituted imidazole core in IZCZ-3 
(Figure 3), 15 and IZFL-2 (Figure 5) indicates its pivotal role in interacting with promoter G4. 
Thus, exploring chemical space around this central core will potentially result in novel small 
molecules with specific binding towards a particular promoter G4 structure.    
It also appears that there exists a fine trade-off between binding affinity and specificity.110 
Many of the universal G4 stabilizing and binding agents such as pyridostatin and BRACO-19 
have their Kd in the nanomolar range (~390 nM for pyridostatin and ~33 nM for BRACO-19)
124, 
125, whereas all the G4 specific ligands (Figure 3) and most of the fluorescent probes (Figure 5) 
have their Kd   in the micromolar range. These results indicate that highly potent G4 binding 
ligands are likely to bind all G4s promiscuously with little or no discrimination. On the other 
hand, G4 specific ligands and probes uphold their biding specificity towards their cognate G4s, 
but with moderate binding affinity. Recently, RNA aptamers named Spinach,126 Broccoli,127 
Corn,128 and Chili129 that bind to GFP chromophore analogues and those named Mango (I to 
IV)130-132 that bind to thiazole orange derivatives have been discovered by in vitro selections or 
reselections or  reengineering. Intriguingly, these aptamers  contain G4 structures, whose G-
quartets are binding sites for the fluorophores.132-135Given their demonstrated applications in 
imaging cellular RNAs, the fluorophores offer an opportunity to explore chemical space around 
them for the development of G4-specific probes for cellular applications.  
The presence of hydroxyethyl and polyethylene glycol groups in ThT-HE, L-1, SQgI, 
CAS-C1 and 2 (Figure 5) suggests that they could be exploited as side chains when designing 
parallel G4 specific ligands, which potentially reduce the nonspecific interactions between the 
positively charged amine side chains in the ligands and negatively charged phosphate backbone 
in the receptor G4s.110 Moreover, the oligoethylene glycols, containing hydrocarbons, ether 
groups, and hydroxyl groups, can interact with G4 nucleic acids through lone pair-π and CH-π 
interactions, besides the hydrogen bonding.136 Therefore, ligands with oligoethylene glycols are 
more likely to result in specific interactions with the receptor G4s.  
The rational design of G4 ligands reported to date, mostly considered non-covalent 
interactions such as stacking, hydrogen bonding, and electrostatic interaction to achieve target 
recognition. Intriguingly, the negatively charged side chains (carboxylic or sulfonic acid groups) 
present in NDI 1, NDI 3, Carbazole TO, 9E BPIC, 15, CSTS (Figure 3 and 5) hint that they 
can also be used for the development of structure-specific fluorescent probes, albeit their role 
remains unclear besides improving water solubility. Further, the presence of hydrophobic t-Butyl 
groups in NDI-1, NDI-3, and 12 (Figure 3) implies that other non-covalent interactions are 
likely to play to key roles in recognizing a particular promoter G4 topology.  
The selectivity of most of the probes (Figure 5 and Table 1) needs to be improved. As 
the field is burgeoning, advances in the molecular engineering will likely result in next-
generation probes with superior selectivity towards the targeted G4 over others. Overall, the 
quest for the G4-specific ligands and probes is being actively pursued and this will bring out 
novel drug-like small molecules and smart fluorescent probes, which in turn may find 
applications in G4-based therapeutics, diagnostics and sensing.   
Keywords 
Quadruplexes (G4s): Four-stranded nucleic acids consisting of two or more G-quartets formed 
by guanine (G)-rich sequences. 
Parallel G4s: G4s whose all four strands orient into the same direction and in the case of 
intramolecular ones, the strands are further intertwined by three propeller (chain reversal) loops.  
Promoter G4s: Quadruplexes formed from the G-tracts located at the upstream of genes. 
G4 Helicases: Enzymes that unwind (unfold) the G4 structures. 
G4 ligands: Ligands (small molecules) that bind to G4 nucleic acids. 
Dissociation constant (Kd): Concentration of ligand at which 50% of the G4 exists in the G4-
ligand complex. 
Conformational selection: Ligand binds to one of the preexisting G4 conformations, and 
consequently shifts the ensemble towards the ligand-favoured conformation.   
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